<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[regimen Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/regimen.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to regimen]]></description>
	<s:counts start="0" returned="20" found="44" />
	<language>en-us</language>
	<item>
		<title><![CDATA[SuperGen, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-325421.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instruction Your first question comes from the line of Boris Peaker  - Rodman & Renshaw. Boris Peaker - Rodman & Renshaw, Inc.  Can you hear me? James Manuso Yes. Thank you. Boris Peaker - Rodman & Renshaw, Inc.  I have a...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 27 Jul 2009 18:09:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[Regimen]]></category>
		<category domain="http://resources.bnet.com/topic/supergen+inc..html"><![CDATA[SuperGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/tim.html"><![CDATA[Tim]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SUPG</category>
		<category domain="tickers">SUPG</category>
	</item>
	<item>
		<title><![CDATA[Data from Phase II Clinical Trial of Galiximab in Combination with Rituximab in Patients with Previously Untreated Follicular Lymphoma Presented at International Conference on Malignant Lymphoma]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_7/ai_n25489824]]></link>
		<description><![CDATA[LUGANO, Switzerland -- The Cancer and Leukemia Group B CALGB today announced data from a phase II clinical trial showing that 70 percent of patients with previously untreated follicular lymphoma responded to treatment with galiximab, an investigational anti-CD80 monoclonal antibody, when given in combination with rituximab. Of the 61 patients...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 07 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[MabThera Receives Positive Opinion in Europe for Combination With Any Chemotherapy Regimen in First-Line Treatment for Follicular Non-Hodgkin's Lymphoma.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200712/ai_n23678315]]></link>
		<description><![CDATA[BASEL, Switzerland, December 14 /PRNewswire/ --    - Physicians Will be Able to Prescribe MabThera With Their  Preferred Chemotherapy Regimen as Initial Treatment    Roche announced today that the European Union's Committee on  Human Medical Products CHMP has given a positive recommendation for ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 14 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/physician.html"><![CDATA[physician]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200707/ai_n19770889]]></link>
		<description><![CDATA[M2 PRESSWIRE-11 July 2007-EIExplorationInvestor: Pixantrone  Combination Therapy for First-line Treatment of Aggressive  Non-Hodgkin's Lymphoma Results in Reduction in Severe  ToxicitiesC1994-2007 M2 COMMUNICATIONS LTD    RDATE:11072007    Exploration Investor strives to provide you with outstanding market  results. We will be your number one...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 11 Jul 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[For the feet.(SPA and SALON: new professional products, promotions and events)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb129/is_200706/ai_n26192719]]></link>
		<description><![CDATA[Salvona Technologies Inc., in alliance with EverythingFeet, LLC,  introduced PediNova. The three-step skin care regimen for feet consists  of a moisturizing cream, an intensive exfoliating scrub and a daily  exfoliating scrub. The products are formulated using MultiSal Salicylic  Acid 30 and are based on the company's...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[alliance]]></category>
		<category domain="http://resources.bnet.com/topic/cream.html"><![CDATA[cream]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/salon.html"><![CDATA[Salon]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Nuvelo Receives FDA Fast Track Status of Metastatic Colorectal Cancer.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200703/ai_n20187283]]></link>
		<description><![CDATA[M2 PRESSWIRE-27 March 2007-Morning Movers: Nuvelo Receives FDA Fast  Track Status of Metastatic Colorectal CancerC1994-2007 M2  COMMUNICATIONS LTD    RDATE:27032007    Market Gainer is quickly emerging as the one stop shop for  international small-cap investors looking to stay a step ahead of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[security]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Indevus Reports Interim Review of NEBIDO Phase III Data Indicates Trial Is Likely to Succeed.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200703/ai_n20184357]]></link>
		<description><![CDATA[M2 PRESSWIRE-26 March 2007-News Flash: Indevus Reports Interim  Review of NEBIDO Phase III Data Indicates Trial Is Likely to  SucceedC1994-2007 M2 COMMUNICATIONS LTD    RDATE:26032007    Market Gainer is quickly emerging as the one stop shop for  international small-cap investors looking to stay...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 26 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200703/ai_n23963334]]></link>
		<description><![CDATA[Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load,       in Combination Therapy Across Range of Treatment-Experienced Patients    Pivotal Data Presented at the 14th Conference on Retroviruses and Opportunistic            ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 02 Mar 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Hair recovery.(SPA and SALON: new professional products, promotions and events)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb129/is_200703/ai_n26192182]]></link>
		<description><![CDATA[JOICO introduced its Moisture Recovery hair care regimen for dry  hair attributed to a variety of causes. It features Hydramine Sea  Complex--a blend of algae, sea kelp and marine-derived amino acids and  minerals--Murumuru butter, jojoba oil and shea butter. The regimen  includes shampoo, conditioner, a treatment...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Mar 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/blend.html"><![CDATA[blend]]></category>
		<category domain="http://resources.bnet.com/topic/recovery.html"><![CDATA[recovery]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/salon.html"><![CDATA[Salon]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mayo Clinic Cancer Center Collaborating to Find New Tools to Fight Leukemia]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200612/ai_n21883442]]></link>
		<description><![CDATA[To: National Desk, Health ReporterContact: Elizabeth Zimmermann of Mayo Clinic, 507-284-5005 or 507- 284-2511 evenings, or newsbureau@mayo.eduORLANDO, Fla., Dec. 10 /U.S. Newswire/ -- Mayo Clinic Cancer Center, working in collaboration with Ohio State University Comprehensive Cancer Center, presented evidence Sunday that a novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 10 Dec 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/m.d..html"><![CDATA[M.D.]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[researcher]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[New research confirms AIDS drugs a lifeline for Africa]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200608/ai_n16622635]]></link>
		<description><![CDATA[TORONTO AFP &#8212; HIV drugs that are now at last reaching sub-Saharan Africa can be administered safely and effectively, saving lives there just as they have in rich countries, according to research presented at the world AIDS conference.  The evidence powerfully backs the arguments of campaigners who for years...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 13 Aug 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Squibb and Gilead Sciences Submit New Drug Application to U.S. FDA for a Once-Daily Single Tablet Regimen of SustivaŽ  and TruvadaŽ  for HIV Treatment]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_April_27/ai_n26841482]]></link>
		<description><![CDATA[PRINCETON, N.J. & FOSTER CITY, Calif. -- Bristol-Myers Squibb Company (NYSE:BMY) and Gilead Sciences, Inc. (Nasdaq:GILD) today announced the submission of a New Drug Application NDA to the U.S. Food and Drug Administration FDA for approval of a product that combines the anti-HIV medications SustivaR efavirenz, manufactured by Bristol-Myers Squibb,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Apr 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/gilead+sciences+inc..html"><![CDATA[Gilead Sciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
		<category domain="tickers">BMY,GILD</category>
	</item>
	<item>
		<title><![CDATA[Mississippi meltdown.(STATELINE)(obese people)(Brief article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6363/is_200604/ai_n26667720]]></link>
		<description><![CDATA[The chairmen of the Mississippi House and Senate public health  committees stepped on digital scales in the Capitol rotunda in  mid-January to begin a 10-week regimen of self improvement.  Representative Steve Holland and Senator Alan Nunnelee have worn  pedometers and given up fatty foods to try...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 01 Apr 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/holland.html"><![CDATA[Holland]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/senator.html"><![CDATA[senator]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+senate.html"><![CDATA[U.S. Senate]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200511/ai_n23958739]]></link>
		<description><![CDATA[New Data Show Hypertensive Patients Taking Norvasc-Based Regimen Achieved                    Better Central Blood Pressure Control    Central Blood Pressure Shown to Be an Independent Predictor of Cardiovascular   ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[blood pressure]]></category>
		<category domain="http://resources.bnet.com/topic/cafe.html"><![CDATA[Cafe]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Cost-Effectiveness of 4 Empiric Antimicrobial Regimens in Patients With Community-Acquired Pneumonia]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=158998]]></link>
		<description><![CDATA[This study compares the cost-effectiveness of the 4 most common empiric antimicrobial regimens used for the treatment of adults with Community-Acquired Pneumonia CAP at a community health system during a 6-month period. Associations between initial antimicrobials and total hospital costs were determined. Cost-effectiveness ratios were determined by dividing the total...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 01 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[Regimen]]></category>
		<category domain="http://resources.bnet.com/topic/skyscape+inc..html"><![CDATA[Skyscape Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
	</item>
	<item>
		<title><![CDATA[US bakers get a rise out of Atkins woes]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200508/ai_n14846675]]></link>
		<description><![CDATA[NEW YORK AFP &#8212; Signs that the low-carb food trend championed by the Atkins diet has run its course are being greeted with relief by some in the US food industry who had struggled with a market-shaking shift in eating habits.  The downturn in popularity of the once pervasive...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Aug 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/bankruptcy.html"><![CDATA[bankruptcy]]></category>
		<category domain="http://resources.bnet.com/topic/bread.html"><![CDATA[bread]]></category>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[food]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/nutrition.html"><![CDATA[nutrition]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mediterranean diet boosts longevity among elderly: study]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200504/ai_n14744560]]></link>
		<description><![CDATA[PARIS AFP &#8212; A large-scale study published adds statistical evidence to the perceived benefits of the Mediterranean diet, a regimen rich in fish, olive oil, fruits, vegetables and cereals and supplemented by a modest intake of red wine.  In an assessment of nearly 75,000 people aged over 60 in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Apr 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/cereal.html"><![CDATA[cereal]]></category>
		<category domain="http://resources.bnet.com/topic/olive.html"><![CDATA[olive]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/vegetable.html"><![CDATA[vegetable]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[DATA Reacts to FDA Approval of Generic AIDS Drug Regimen]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200501/ai_n21848993]]></link>
		<description><![CDATA[WASHINGTON, Jan. 25 /U.S. Newswire/ -- Today, the U.S. Food and Drug Administration FDA announced the tentative approval of an AIDS drug regimen manufactured in South Africa for the treatment of HIV-1 in adults. This approval clears the way for the procWASHINGTON, Jan. 25 /U.S. Newswire/ -- Today, the U.S....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 25 Jan 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Improved Dosing Regimens and Novel Mechanisms of Action Drive Osteoporosis Therapeutics Markets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Jan_18/ai_n8696457]]></link>
		<description><![CDATA[PALO ALTO, Calif. -- The introduction of new products with either expanded indications, improved dosing regimens or bone-building capabilities is expected to drive the U.S. osteoporosis therapies market forward in the years to come.  New analysis from Frost & Sullivan (http://www.healthcare.frost.com), U.S. Osteoporosis Therapeutics Markets, reveals that revenue in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 18 Jan 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Phase I/II Experience of Pixantrone CHOP-Variant (CPOP) Produces Responses in 70 Percent of Relapsed Aggressive Non-Hodgkin's Lymphoma Patients Who Previously Failed CHOP Chemotherapy.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200412/ai_n24118431]]></link>
		<description><![CDATA[SAN DIEGO, December 6 /PRNewswire/ --    - Complete Responses Seen in 47 Percent of Patients    Preliminary results of a phase II study of a variant of the CHOP  chemotherapy regimen which replaces doxorubicin with pixantrone in  patients with relapsed aggressive non-Hodgkin's lymphoma...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 06 Dec 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/regimen.html"><![CDATA[regimen]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
